Skip to main content
. 2019 Mar 14;36(5):1190–1199. doi: 10.1007/s12325-019-00915-8

Fig. 3.

Fig. 3

Relative cost of bringing patients to a glycated hemoglobin target of 7% or lower without hypoglycemia and without weight gain with once-weekly semaglutide 0.5 mg versus dulaglutide 0.75 mg and 1.5 mg